Aytu BioPharma conducted its earnings call for the fiscal 2026 third quarter on May 13, 2026. Executives discussed operational and financial results for the period ended March 31, 2026.
The conference call began at 4:30 PM EDT with an introduction from investor relations representative Robert Blum of Lytham Partners. Chief Executive Officer Joshua Disbrow and Chief Financial Officer Ryan J. Selhorn joined to review company performance. Analysts from firms including Lake Street Capital Markets and Ascendiant Capital Markets participated in the session.